Efficacy of HER2-targeted therapy for patients with HER2-positive breast cancer according to hormone receptor status.

Research output: Contribution to journal › Article

Original language	English
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	31
Issue number	26
DOIs	https://doi.org/10.1200/jco.2013.31.26_suppl.97
State	Published - Sep 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{7537b7c7ce5a40f5bc3edd471d368693,

title = "Efficacy of HER2-targeted therapy for patients with HER2-positive breast cancer according to hormone receptor status.",

author = "Takeshi Murata and Maiko Takahashi and Tetsu Hayashida and Hiromitsu Jinno and Yuko Kitagawa",

year = "2013",

month = sep,

doi = "10.1200/jco.2013.31.26\_suppl.97",

language = "英語",

volume = "31",

journal = "JOURNAL OF CLINICAL ONCOLOGY",

issn = "0732-183X",

number = "26",

}

TY - JOUR

T1 - Efficacy of HER2-targeted therapy for patients with HER2-positive breast cancer according to hormone receptor status.

AU - Murata, Takeshi

AU - Takahashi, Maiko

AU - Hayashida, Tetsu

AU - Jinno, Hiromitsu

AU - Kitagawa, Yuko

PY - 2013/9

Y1 - 2013/9

U2 - 10.1200/jco.2013.31.26_suppl.97

DO - 10.1200/jco.2013.31.26_suppl.97

M3 - 記事

SN - 0732-183X

VL - 31

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 26

ER -